nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—Cytochrome P450 3A5 Inhibitors—Ticagrelor—coronary artery disease	0.485	0.82	CiPCiCtD
Boceprevir—Cytochrome P450 3A4 Inhibitors—Ticagrelor—coronary artery disease	0.106	0.18	CiPCiCtD
Boceprevir—ABCB1—Ticagrelor—coronary artery disease	0.0124	0.0593	CbGbCtD
Boceprevir—CYP3A5—Clopidogrel—coronary artery disease	0.0118	0.0563	CbGbCtD
Boceprevir—CYP3A5—Eplerenone—coronary artery disease	0.011	0.0523	CbGbCtD
Boceprevir—CMA1—tunica intima—coronary artery disease	0.00807	0.306	CbGeAlD
Boceprevir—ABCB1—Clopidogrel—coronary artery disease	0.00768	0.0366	CbGbCtD
Boceprevir—ABCB1—Perindopril—coronary artery disease	0.00768	0.0366	CbGbCtD
Boceprevir—CYP3A5—Rosuvastatin—coronary artery disease	0.0076	0.0363	CbGbCtD
Boceprevir—CYP3A4—Ticagrelor—coronary artery disease	0.00745	0.0355	CbGbCtD
Boceprevir—CYP3A5—Simvastatin—coronary artery disease	0.00707	0.0337	CbGbCtD
Boceprevir—CYP3A5—Lovastatin—coronary artery disease	0.00692	0.033	CbGbCtD
Boceprevir—CYP3A5—Pravastatin—coronary artery disease	0.00692	0.033	CbGbCtD
Boceprevir—ABCB1—Telmisartan—coronary artery disease	0.00671	0.032	CbGbCtD
Boceprevir—ABCB1—Pitavastatin—coronary artery disease	0.00671	0.032	CbGbCtD
Boceprevir—CYP3A4—Fenofibrate—coronary artery disease	0.00664	0.0317	CbGbCtD
Boceprevir—ABCB1—Enalapril—coronary artery disease	0.00636	0.0304	CbGbCtD
Boceprevir—ABCB1—Lisinopril—coronary artery disease	0.00636	0.0304	CbGbCtD
Boceprevir—CYP3A5—Atorvastatin—coronary artery disease	0.0063	0.0301	CbGbCtD
Boceprevir—CYP3A5—Losartan—coronary artery disease	0.00576	0.0275	CbGbCtD
Boceprevir—ABCB1—Timolol—coronary artery disease	0.00541	0.0258	CbGbCtD
Boceprevir—CYP3A4—Gemfibrozil—coronary artery disease	0.0053	0.0253	CbGbCtD
Boceprevir—ABCB1—Ezetimibe—coronary artery disease	0.00495	0.0236	CbGbCtD
Boceprevir—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00482	0.023	CbGbCtD
Boceprevir—ABCB1—Captopril—coronary artery disease	0.00476	0.0227	CbGbCtD
Boceprevir—CYP3A4—Clopidogrel—coronary artery disease	0.0046	0.022	CbGbCtD
Boceprevir—ABCB1—Simvastatin—coronary artery disease	0.0046	0.0219	CbGbCtD
Boceprevir—ABCB1—Lovastatin—coronary artery disease	0.0045	0.0215	CbGbCtD
Boceprevir—ABCB1—Pravastatin—coronary artery disease	0.0045	0.0215	CbGbCtD
Boceprevir—CYP3A4—Eplerenone—coronary artery disease	0.00428	0.0204	CbGbCtD
Boceprevir—ABCB1—Atorvastatin—coronary artery disease	0.0041	0.0196	CbGbCtD
Boceprevir—CYP3A4—Enalapril—coronary artery disease	0.00381	0.0182	CbGbCtD
Boceprevir—ABCB1—Losartan—coronary artery disease	0.00375	0.0179	CbGbCtD
Boceprevir—CYP3A4—Rosuvastatin—coronary artery disease	0.00296	0.0141	CbGbCtD
Boceprevir—CYP3A4—Ezetimibe—coronary artery disease	0.00296	0.0141	CbGbCtD
Boceprevir—CMA1—artery—coronary artery disease	0.00276	0.105	CbGeAlD
Boceprevir—CYP3A4—Simvastatin—coronary artery disease	0.00276	0.0132	CbGbCtD
Boceprevir—CYP3A4—Lovastatin—coronary artery disease	0.0027	0.0129	CbGbCtD
Boceprevir—CYP3A4—Pravastatin—coronary artery disease	0.0027	0.0129	CbGbCtD
Boceprevir—CYP3A4—Atorvastatin—coronary artery disease	0.00246	0.0117	CbGbCtD
Boceprevir—CYP3A4—Losartan—coronary artery disease	0.00225	0.0107	CbGbCtD
Boceprevir—CTSL—cardiac ventricle—coronary artery disease	0.00133	0.0502	CbGeAlD
Boceprevir—CTSL—myocardium—coronary artery disease	0.00125	0.0473	CbGeAlD
Boceprevir—CMA1—heart—coronary artery disease	0.00102	0.0386	CbGeAlD
Boceprevir—CTSK—cardiac ventricle—coronary artery disease	0.000999	0.0379	CbGeAlD
Boceprevir—CMA1—cardiovascular system—coronary artery disease	0.00096	0.0364	CbGeAlD
Boceprevir—CTSK—myocardium—coronary artery disease	0.000939	0.0356	CbGeAlD
Boceprevir—CTSL—heart—coronary artery disease	0.00087	0.033	CbGeAlD
Boceprevir—CTSS—myocardium—coronary artery disease	0.000823	0.0312	CbGeAlD
Boceprevir—CTSL—cardiovascular system—coronary artery disease	0.000821	0.0311	CbGeAlD
Boceprevir—CMA1—blood—coronary artery disease	0.000759	0.0288	CbGeAlD
Boceprevir—CTSL—cardiac atrium—coronary artery disease	0.000744	0.0282	CbGeAlD
Boceprevir—CTSK—heart—coronary artery disease	0.000656	0.0249	CbGeAlD
Boceprevir—CTSL—blood—coronary artery disease	0.000649	0.0246	CbGeAlD
Boceprevir—CTSK—cardiovascular system—coronary artery disease	0.000619	0.0235	CbGeAlD
Boceprevir—CTSS—heart—coronary artery disease	0.000575	0.0218	CbGeAlD
Boceprevir—CTSK—cardiac atrium—coronary artery disease	0.000561	0.0213	CbGeAlD
Boceprevir—CTSS—cardiovascular system—coronary artery disease	0.000542	0.0206	CbGeAlD
Boceprevir—CTSK—blood—coronary artery disease	0.000489	0.0185	CbGeAlD
Boceprevir—CTSS—blood—coronary artery disease	0.000429	0.0163	CbGeAlD
Boceprevir—Telaprevir—ALB—coronary artery disease	0.000281	1	CrCbGaD
Boceprevir—CYP3A5—blood—coronary artery disease	0.000142	0.0054	CbGeAlD
Boceprevir—CYP3A4—blood—coronary artery disease	0.000107	0.00405	CbGeAlD
Boceprevir—ABCB1—heart—coronary artery disease	0.000101	0.00384	CbGeAlD
Boceprevir—ABCB1—cardiovascular system—coronary artery disease	9.56e-05	0.00363	CbGeAlD
Boceprevir—ABCB1—blood—coronary artery disease	7.56e-05	0.00287	CbGeAlD
Boceprevir—Decreased appetite—Losartan—coronary artery disease	2.05e-05	0.000211	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	2.05e-05	0.000211	CcSEcCtD
Boceprevir—Abdominal pain—Captopril—coronary artery disease	2.05e-05	0.000211	CcSEcCtD
Boceprevir—Body temperature increased—Captopril—coronary artery disease	2.05e-05	0.000211	CcSEcCtD
Boceprevir—Dizziness—Simvastatin—coronary artery disease	2.05e-05	0.00021	CcSEcCtD
Boceprevir—Rash—Ezetimibe—coronary artery disease	2.05e-05	0.00021	CcSEcCtD
Boceprevir—Dermatitis—Ezetimibe—coronary artery disease	2.04e-05	0.00021	CcSEcCtD
Boceprevir—Confusional state—Ramipril—coronary artery disease	2.04e-05	0.00021	CcSEcCtD
Boceprevir—Discomfort—Timolol—coronary artery disease	2.04e-05	0.00021	CcSEcCtD
Boceprevir—Asthenia—Niacin—coronary artery disease	2.04e-05	0.000209	CcSEcCtD
Boceprevir—Fatigue—Losartan—coronary artery disease	2.04e-05	0.000209	CcSEcCtD
Boceprevir—Headache—Ezetimibe—coronary artery disease	2.03e-05	0.000209	CcSEcCtD
Boceprevir—Malaise—Lisinopril—coronary artery disease	2.03e-05	0.000209	CcSEcCtD
Boceprevir—Vertigo—Lisinopril—coronary artery disease	2.02e-05	0.000208	CcSEcCtD
Boceprevir—Dry mouth—Timolol—coronary artery disease	2.02e-05	0.000208	CcSEcCtD
Boceprevir—Constipation—Losartan—coronary artery disease	2.02e-05	0.000208	CcSEcCtD
Boceprevir—Pain—Losartan—coronary artery disease	2.02e-05	0.000208	CcSEcCtD
Boceprevir—Syncope—Lisinopril—coronary artery disease	2.02e-05	0.000207	CcSEcCtD
Boceprevir—Vomiting—Eplerenone—coronary artery disease	2.02e-05	0.000207	CcSEcCtD
Boceprevir—Feeling abnormal—Furosemide—coronary artery disease	2.02e-05	0.000207	CcSEcCtD
Boceprevir—Leukopenia—Lisinopril—coronary artery disease	2.02e-05	0.000207	CcSEcCtD
Boceprevir—Nausea—Fenofibrate—coronary artery disease	2.01e-05	0.000207	CcSEcCtD
Boceprevir—Pruritus—Niacin—coronary artery disease	2.01e-05	0.000207	CcSEcCtD
Boceprevir—Asthenia—Pravastatin—coronary artery disease	2.01e-05	0.000206	CcSEcCtD
Boceprevir—Gastrointestinal pain—Furosemide—coronary artery disease	2e-05	0.000206	CcSEcCtD
Boceprevir—Rash—Eplerenone—coronary artery disease	2e-05	0.000206	CcSEcCtD
Boceprevir—Urticaria—Perindopril—coronary artery disease	2e-05	0.000206	CcSEcCtD
Boceprevir—Hypersensitivity—Trandolapril—coronary artery disease	2e-05	0.000206	CcSEcCtD
Boceprevir—Dermatitis—Eplerenone—coronary artery disease	2e-05	0.000206	CcSEcCtD
Boceprevir—Diarrhoea—Valsartan—coronary artery disease	2e-05	0.000205	CcSEcCtD
Boceprevir—Confusional state—Timolol—coronary artery disease	2e-05	0.000205	CcSEcCtD
Boceprevir—Shock—Ramipril—coronary artery disease	1.99e-05	0.000205	CcSEcCtD
Boceprevir—Hypersensitivity—Enalapril—coronary artery disease	1.99e-05	0.000205	CcSEcCtD
Boceprevir—Body temperature increased—Perindopril—coronary artery disease	1.99e-05	0.000205	CcSEcCtD
Boceprevir—Abdominal pain—Perindopril—coronary artery disease	1.99e-05	0.000205	CcSEcCtD
Boceprevir—Palpitations—Lisinopril—coronary artery disease	1.99e-05	0.000204	CcSEcCtD
Boceprevir—Diarrhoea—Olmesartan—coronary artery disease	1.99e-05	0.000204	CcSEcCtD
Boceprevir—Headache—Eplerenone—coronary artery disease	1.99e-05	0.000204	CcSEcCtD
Boceprevir—Nervous system disorder—Ramipril—coronary artery disease	1.99e-05	0.000204	CcSEcCtD
Boceprevir—Thrombocytopenia—Ramipril—coronary artery disease	1.98e-05	0.000204	CcSEcCtD
Boceprevir—Pruritus—Pravastatin—coronary artery disease	1.98e-05	0.000203	CcSEcCtD
Boceprevir—Loss of consciousness—Lisinopril—coronary artery disease	1.98e-05	0.000203	CcSEcCtD
Boceprevir—Nausea—Clopidogrel—coronary artery disease	1.98e-05	0.000203	CcSEcCtD
Boceprevir—Tachycardia—Ramipril—coronary artery disease	1.98e-05	0.000203	CcSEcCtD
Boceprevir—Skin disorder—Ramipril—coronary artery disease	1.97e-05	0.000202	CcSEcCtD
Boceprevir—Infection—Timolol—coronary artery disease	1.97e-05	0.000202	CcSEcCtD
Boceprevir—Vomiting—Simvastatin—coronary artery disease	1.97e-05	0.000202	CcSEcCtD
Boceprevir—Hypersensitivity—Telmisartan—coronary artery disease	1.97e-05	0.000202	CcSEcCtD
Boceprevir—Cough—Lisinopril—coronary artery disease	1.96e-05	0.000202	CcSEcCtD
Boceprevir—Nausea—Lovastatin—coronary artery disease	1.96e-05	0.000202	CcSEcCtD
Boceprevir—Hyperhidrosis—Ramipril—coronary artery disease	1.96e-05	0.000201	CcSEcCtD
Boceprevir—Rash—Simvastatin—coronary artery disease	1.95e-05	0.0002	CcSEcCtD
Boceprevir—Dermatitis—Simvastatin—coronary artery disease	1.95e-05	0.0002	CcSEcCtD
Boceprevir—Asthenia—Trandolapril—coronary artery disease	1.95e-05	0.0002	CcSEcCtD
Boceprevir—Shock—Timolol—coronary artery disease	1.95e-05	0.0002	CcSEcCtD
Boceprevir—Feeling abnormal—Losartan—coronary artery disease	1.95e-05	0.0002	CcSEcCtD
Boceprevir—Urticaria—Furosemide—coronary artery disease	1.95e-05	0.0002	CcSEcCtD
Boceprevir—Diarrhoea—Niacin—coronary artery disease	1.94e-05	0.0002	CcSEcCtD
Boceprevir—Nervous system disorder—Timolol—coronary artery disease	1.94e-05	0.0002	CcSEcCtD
Boceprevir—Asthenia—Enalapril—coronary artery disease	1.94e-05	0.000199	CcSEcCtD
Boceprevir—Headache—Simvastatin—coronary artery disease	1.94e-05	0.000199	CcSEcCtD
Boceprevir—Body temperature increased—Furosemide—coronary artery disease	1.94e-05	0.000199	CcSEcCtD
Boceprevir—Abdominal pain—Furosemide—coronary artery disease	1.94e-05	0.000199	CcSEcCtD
Boceprevir—Gastrointestinal pain—Losartan—coronary artery disease	1.93e-05	0.000199	CcSEcCtD
Boceprevir—Dizziness—Valsartan—coronary artery disease	1.93e-05	0.000199	CcSEcCtD
Boceprevir—Nausea—Ezetimibe—coronary artery disease	1.93e-05	0.000198	CcSEcCtD
Boceprevir—Skin disorder—Timolol—coronary artery disease	1.92e-05	0.000198	CcSEcCtD
Boceprevir—Dizziness—Olmesartan—coronary artery disease	1.92e-05	0.000198	CcSEcCtD
Boceprevir—Pruritus—Trandolapril—coronary artery disease	1.92e-05	0.000197	CcSEcCtD
Boceprevir—Myalgia—Lisinopril—coronary artery disease	1.92e-05	0.000197	CcSEcCtD
Boceprevir—Arthralgia—Lisinopril—coronary artery disease	1.92e-05	0.000197	CcSEcCtD
Boceprevir—Chest pain—Lisinopril—coronary artery disease	1.92e-05	0.000197	CcSEcCtD
Boceprevir—Hyperhidrosis—Timolol—coronary artery disease	1.91e-05	0.000197	CcSEcCtD
Boceprevir—Asthenia—Telmisartan—coronary artery disease	1.91e-05	0.000197	CcSEcCtD
Boceprevir—Pruritus—Enalapril—coronary artery disease	1.91e-05	0.000197	CcSEcCtD
Boceprevir—Diarrhoea—Pravastatin—coronary artery disease	1.91e-05	0.000197	CcSEcCtD
Boceprevir—Anxiety—Lisinopril—coronary artery disease	1.91e-05	0.000196	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	1.9e-05	0.000196	CcSEcCtD
Boceprevir—Discomfort—Lisinopril—coronary artery disease	1.89e-05	0.000195	CcSEcCtD
Boceprevir—Hypotension—Ramipril—coronary artery disease	1.89e-05	0.000195	CcSEcCtD
Boceprevir—Pruritus—Telmisartan—coronary artery disease	1.89e-05	0.000194	CcSEcCtD
Boceprevir—Nausea—Eplerenone—coronary artery disease	1.89e-05	0.000194	CcSEcCtD
Boceprevir—Dizziness—Niacin—coronary artery disease	1.88e-05	0.000193	CcSEcCtD
Boceprevir—Urticaria—Losartan—coronary artery disease	1.88e-05	0.000193	CcSEcCtD
Boceprevir—Dry mouth—Lisinopril—coronary artery disease	1.87e-05	0.000193	CcSEcCtD
Boceprevir—Abdominal pain—Losartan—coronary artery disease	1.87e-05	0.000192	CcSEcCtD
Boceprevir—Body temperature increased—Losartan—coronary artery disease	1.87e-05	0.000192	CcSEcCtD
Boceprevir—Asthenia—Captopril—coronary artery disease	1.86e-05	0.000191	CcSEcCtD
Boceprevir—Diarrhoea—Trandolapril—coronary artery disease	1.86e-05	0.000191	CcSEcCtD
Boceprevir—Vomiting—Valsartan—coronary artery disease	1.86e-05	0.000191	CcSEcCtD
Boceprevir—Confusional state—Lisinopril—coronary artery disease	1.85e-05	0.00019	CcSEcCtD
Boceprevir—Diarrhoea—Enalapril—coronary artery disease	1.85e-05	0.00019	CcSEcCtD
Boceprevir—Hypotension—Timolol—coronary artery disease	1.85e-05	0.00019	CcSEcCtD
Boceprevir—Dizziness—Pravastatin—coronary artery disease	1.85e-05	0.00019	CcSEcCtD
Boceprevir—Vomiting—Olmesartan—coronary artery disease	1.85e-05	0.00019	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Ramipril—coronary artery disease	1.85e-05	0.00019	CcSEcCtD
Boceprevir—Rash—Valsartan—coronary artery disease	1.84e-05	0.000189	CcSEcCtD
Boceprevir—Dermatitis—Valsartan—coronary artery disease	1.84e-05	0.000189	CcSEcCtD
Boceprevir—Nausea—Simvastatin—coronary artery disease	1.84e-05	0.000189	CcSEcCtD
Boceprevir—Pruritus—Captopril—coronary artery disease	1.84e-05	0.000189	CcSEcCtD
Boceprevir—Rash—Olmesartan—coronary artery disease	1.83e-05	0.000188	CcSEcCtD
Boceprevir—Insomnia—Ramipril—coronary artery disease	1.83e-05	0.000188	CcSEcCtD
Boceprevir—Dermatitis—Olmesartan—coronary artery disease	1.83e-05	0.000188	CcSEcCtD
Boceprevir—Headache—Valsartan—coronary artery disease	1.83e-05	0.000188	CcSEcCtD
Boceprevir—Diarrhoea—Telmisartan—coronary artery disease	1.83e-05	0.000188	CcSEcCtD
Boceprevir—Infection—Lisinopril—coronary artery disease	1.83e-05	0.000188	CcSEcCtD
Boceprevir—Headache—Olmesartan—coronary artery disease	1.82e-05	0.000187	CcSEcCtD
Boceprevir—Paraesthesia—Ramipril—coronary artery disease	1.82e-05	0.000187	CcSEcCtD
Boceprevir—Shock—Lisinopril—coronary artery disease	1.81e-05	0.000186	CcSEcCtD
Boceprevir—Asthenia—Perindopril—coronary artery disease	1.81e-05	0.000186	CcSEcCtD
Boceprevir—Dyspnoea—Ramipril—coronary artery disease	1.81e-05	0.000186	CcSEcCtD
Boceprevir—Vomiting—Niacin—coronary artery disease	1.81e-05	0.000186	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Timolol—coronary artery disease	1.8e-05	0.000185	CcSEcCtD
Boceprevir—Hypersensitivity—Furosemide—coronary artery disease	1.8e-05	0.000185	CcSEcCtD
Boceprevir—Thrombocytopenia—Lisinopril—coronary artery disease	1.8e-05	0.000185	CcSEcCtD
Boceprevir—Dizziness—Trandolapril—coronary artery disease	1.8e-05	0.000185	CcSEcCtD
Boceprevir—Tachycardia—Lisinopril—coronary artery disease	1.79e-05	0.000184	CcSEcCtD
Boceprevir—Insomnia—Timolol—coronary artery disease	1.79e-05	0.000184	CcSEcCtD
Boceprevir—Rash—Niacin—coronary artery disease	1.79e-05	0.000184	CcSEcCtD
Boceprevir—Dermatitis—Niacin—coronary artery disease	1.79e-05	0.000184	CcSEcCtD
Boceprevir—Dizziness—Enalapril—coronary artery disease	1.79e-05	0.000184	CcSEcCtD
Boceprevir—Skin disorder—Lisinopril—coronary artery disease	1.78e-05	0.000183	CcSEcCtD
Boceprevir—Dyspepsia—Ramipril—coronary artery disease	1.78e-05	0.000183	CcSEcCtD
Boceprevir—Pruritus—Perindopril—coronary artery disease	1.78e-05	0.000183	CcSEcCtD
Boceprevir—Headache—Niacin—coronary artery disease	1.78e-05	0.000183	CcSEcCtD
Boceprevir—Paraesthesia—Timolol—coronary artery disease	1.78e-05	0.000183	CcSEcCtD
Boceprevir—Vomiting—Pravastatin—coronary artery disease	1.78e-05	0.000183	CcSEcCtD
Boceprevir—Hyperhidrosis—Lisinopril—coronary artery disease	1.78e-05	0.000183	CcSEcCtD
Boceprevir—Diarrhoea—Captopril—coronary artery disease	1.78e-05	0.000182	CcSEcCtD
Boceprevir—Dyspnoea—Timolol—coronary artery disease	1.77e-05	0.000181	CcSEcCtD
Boceprevir—Dizziness—Telmisartan—coronary artery disease	1.76e-05	0.000181	CcSEcCtD
Boceprevir—Rash—Pravastatin—coronary artery disease	1.76e-05	0.000181	CcSEcCtD
Boceprevir—Dermatitis—Pravastatin—coronary artery disease	1.76e-05	0.000181	CcSEcCtD
Boceprevir—Decreased appetite—Ramipril—coronary artery disease	1.76e-05	0.000181	CcSEcCtD
Boceprevir—Asthenia—Furosemide—coronary artery disease	1.76e-05	0.000181	CcSEcCtD
Boceprevir—Headache—Pravastatin—coronary artery disease	1.75e-05	0.00018	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Ramipril—coronary artery disease	1.75e-05	0.00018	CcSEcCtD
Boceprevir—Fatigue—Ramipril—coronary artery disease	1.75e-05	0.000179	CcSEcCtD
Boceprevir—Dyspepsia—Timolol—coronary artery disease	1.74e-05	0.000179	CcSEcCtD
Boceprevir—Hypersensitivity—Losartan—coronary artery disease	1.74e-05	0.000179	CcSEcCtD
Boceprevir—Nausea—Valsartan—coronary artery disease	1.74e-05	0.000178	CcSEcCtD
Boceprevir—Pruritus—Furosemide—coronary artery disease	1.73e-05	0.000178	CcSEcCtD
Boceprevir—Constipation—Ramipril—coronary artery disease	1.73e-05	0.000178	CcSEcCtD
Boceprevir—Nausea—Olmesartan—coronary artery disease	1.73e-05	0.000177	CcSEcCtD
Boceprevir—Vomiting—Trandolapril—coronary artery disease	1.73e-05	0.000177	CcSEcCtD
Boceprevir—Diarrhoea—Perindopril—coronary artery disease	1.72e-05	0.000177	CcSEcCtD
Boceprevir—Decreased appetite—Timolol—coronary artery disease	1.72e-05	0.000177	CcSEcCtD
Boceprevir—Vomiting—Enalapril—coronary artery disease	1.72e-05	0.000177	CcSEcCtD
Boceprevir—Hypotension—Lisinopril—coronary artery disease	1.72e-05	0.000176	CcSEcCtD
Boceprevir—Dizziness—Captopril—coronary artery disease	1.72e-05	0.000176	CcSEcCtD
Boceprevir—Rash—Trandolapril—coronary artery disease	1.71e-05	0.000176	CcSEcCtD
Boceprevir—Dermatitis—Trandolapril—coronary artery disease	1.71e-05	0.000176	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Timolol—coronary artery disease	1.71e-05	0.000176	CcSEcCtD
Boceprevir—Fatigue—Timolol—coronary artery disease	1.71e-05	0.000175	CcSEcCtD
Boceprevir—Rash—Enalapril—coronary artery disease	1.71e-05	0.000175	CcSEcCtD
Boceprevir—Dermatitis—Enalapril—coronary artery disease	1.7e-05	0.000175	CcSEcCtD
Boceprevir—Headache—Trandolapril—coronary artery disease	1.7e-05	0.000175	CcSEcCtD
Boceprevir—Vomiting—Telmisartan—coronary artery disease	1.7e-05	0.000174	CcSEcCtD
Boceprevir—Asthenia—Losartan—coronary artery disease	1.7e-05	0.000174	CcSEcCtD
Boceprevir—Headache—Enalapril—coronary artery disease	1.69e-05	0.000174	CcSEcCtD
Boceprevir—Pain—Timolol—coronary artery disease	1.69e-05	0.000174	CcSEcCtD
Boceprevir—Nausea—Niacin—coronary artery disease	1.69e-05	0.000173	CcSEcCtD
Boceprevir—Rash—Telmisartan—coronary artery disease	1.68e-05	0.000173	CcSEcCtD
Boceprevir—Dermatitis—Telmisartan—coronary artery disease	1.68e-05	0.000173	CcSEcCtD
Boceprevir—Diarrhoea—Furosemide—coronary artery disease	1.68e-05	0.000172	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Lisinopril—coronary artery disease	1.67e-05	0.000172	CcSEcCtD
Boceprevir—Pruritus—Losartan—coronary artery disease	1.67e-05	0.000172	CcSEcCtD
Boceprevir—Headache—Telmisartan—coronary artery disease	1.67e-05	0.000172	CcSEcCtD
Boceprevir—Feeling abnormal—Ramipril—coronary artery disease	1.67e-05	0.000172	CcSEcCtD
Boceprevir—Dizziness—Perindopril—coronary artery disease	1.67e-05	0.000171	CcSEcCtD
Boceprevir—Insomnia—Lisinopril—coronary artery disease	1.66e-05	0.000171	CcSEcCtD
Boceprevir—Nausea—Pravastatin—coronary artery disease	1.66e-05	0.000171	CcSEcCtD
Boceprevir—Gastrointestinal pain—Ramipril—coronary artery disease	1.66e-05	0.00017	CcSEcCtD
Boceprevir—Paraesthesia—Lisinopril—coronary artery disease	1.65e-05	0.00017	CcSEcCtD
Boceprevir—Vomiting—Captopril—coronary artery disease	1.65e-05	0.00017	CcSEcCtD
Boceprevir—Dyspnoea—Lisinopril—coronary artery disease	1.64e-05	0.000168	CcSEcCtD
Boceprevir—Rash—Captopril—coronary artery disease	1.64e-05	0.000168	CcSEcCtD
Boceprevir—Dermatitis—Captopril—coronary artery disease	1.63e-05	0.000168	CcSEcCtD
Boceprevir—Feeling abnormal—Timolol—coronary artery disease	1.63e-05	0.000168	CcSEcCtD
Boceprevir—Headache—Captopril—coronary artery disease	1.63e-05	0.000167	CcSEcCtD
Boceprevir—Gastrointestinal pain—Timolol—coronary artery disease	1.62e-05	0.000166	CcSEcCtD
Boceprevir—Dizziness—Furosemide—coronary artery disease	1.62e-05	0.000166	CcSEcCtD
Boceprevir—Dyspepsia—Lisinopril—coronary artery disease	1.62e-05	0.000166	CcSEcCtD
Boceprevir—Diarrhoea—Losartan—coronary artery disease	1.62e-05	0.000166	CcSEcCtD
Boceprevir—Nausea—Trandolapril—coronary artery disease	1.61e-05	0.000166	CcSEcCtD
Boceprevir—Urticaria—Ramipril—coronary artery disease	1.61e-05	0.000165	CcSEcCtD
Boceprevir—Nausea—Enalapril—coronary artery disease	1.61e-05	0.000165	CcSEcCtD
Boceprevir—Vomiting—Perindopril—coronary artery disease	1.6e-05	0.000165	CcSEcCtD
Boceprevir—Abdominal pain—Ramipril—coronary artery disease	1.6e-05	0.000165	CcSEcCtD
Boceprevir—Body temperature increased—Ramipril—coronary artery disease	1.6e-05	0.000165	CcSEcCtD
Boceprevir—Decreased appetite—Lisinopril—coronary artery disease	1.6e-05	0.000164	CcSEcCtD
Boceprevir—Rash—Perindopril—coronary artery disease	1.59e-05	0.000163	CcSEcCtD
Boceprevir—Dermatitis—Perindopril—coronary artery disease	1.59e-05	0.000163	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Lisinopril—coronary artery disease	1.59e-05	0.000163	CcSEcCtD
Boceprevir—Nausea—Telmisartan—coronary artery disease	1.59e-05	0.000163	CcSEcCtD
Boceprevir—Fatigue—Lisinopril—coronary artery disease	1.58e-05	0.000163	CcSEcCtD
Boceprevir—Headache—Perindopril—coronary artery disease	1.58e-05	0.000162	CcSEcCtD
Boceprevir—Urticaria—Timolol—coronary artery disease	1.57e-05	0.000162	CcSEcCtD
Boceprevir—Pain—Lisinopril—coronary artery disease	1.57e-05	0.000161	CcSEcCtD
Boceprevir—Constipation—Lisinopril—coronary artery disease	1.57e-05	0.000161	CcSEcCtD
Boceprevir—Abdominal pain—Timolol—coronary artery disease	1.57e-05	0.000161	CcSEcCtD
Boceprevir—Body temperature increased—Timolol—coronary artery disease	1.57e-05	0.000161	CcSEcCtD
Boceprevir—Dizziness—Losartan—coronary artery disease	1.56e-05	0.000161	CcSEcCtD
Boceprevir—Vomiting—Furosemide—coronary artery disease	1.56e-05	0.00016	CcSEcCtD
Boceprevir—Rash—Furosemide—coronary artery disease	1.54e-05	0.000159	CcSEcCtD
Boceprevir—Dermatitis—Furosemide—coronary artery disease	1.54e-05	0.000159	CcSEcCtD
Boceprevir—Nausea—Captopril—coronary artery disease	1.54e-05	0.000158	CcSEcCtD
Boceprevir—Headache—Furosemide—coronary artery disease	1.53e-05	0.000158	CcSEcCtD
Boceprevir—Feeling abnormal—Lisinopril—coronary artery disease	1.51e-05	0.000156	CcSEcCtD
Boceprevir—Gastrointestinal pain—Lisinopril—coronary artery disease	1.5e-05	0.000154	CcSEcCtD
Boceprevir—Vomiting—Losartan—coronary artery disease	1.5e-05	0.000154	CcSEcCtD
Boceprevir—Nausea—Perindopril—coronary artery disease	1.5e-05	0.000154	CcSEcCtD
Boceprevir—Hypersensitivity—Ramipril—coronary artery disease	1.49e-05	0.000153	CcSEcCtD
Boceprevir—Rash—Losartan—coronary artery disease	1.49e-05	0.000153	CcSEcCtD
Boceprevir—Dermatitis—Losartan—coronary artery disease	1.49e-05	0.000153	CcSEcCtD
Boceprevir—Headache—Losartan—coronary artery disease	1.48e-05	0.000152	CcSEcCtD
Boceprevir—Urticaria—Lisinopril—coronary artery disease	1.46e-05	0.00015	CcSEcCtD
Boceprevir—Hypersensitivity—Timolol—coronary artery disease	1.46e-05	0.00015	CcSEcCtD
Boceprevir—Nausea—Furosemide—coronary artery disease	1.45e-05	0.000149	CcSEcCtD
Boceprevir—Asthenia—Ramipril—coronary artery disease	1.45e-05	0.000149	CcSEcCtD
Boceprevir—Abdominal pain—Lisinopril—coronary artery disease	1.45e-05	0.000149	CcSEcCtD
Boceprevir—Body temperature increased—Lisinopril—coronary artery disease	1.45e-05	0.000149	CcSEcCtD
Boceprevir—Pruritus—Ramipril—coronary artery disease	1.43e-05	0.000147	CcSEcCtD
Boceprevir—Asthenia—Timolol—coronary artery disease	1.42e-05	0.000146	CcSEcCtD
Boceprevir—Nausea—Losartan—coronary artery disease	1.4e-05	0.000144	CcSEcCtD
Boceprevir—Pruritus—Timolol—coronary artery disease	1.4e-05	0.000144	CcSEcCtD
Boceprevir—Diarrhoea—Ramipril—coronary artery disease	1.39e-05	0.000142	CcSEcCtD
Boceprevir—Diarrhoea—Timolol—coronary artery disease	1.36e-05	0.000139	CcSEcCtD
Boceprevir—Hypersensitivity—Lisinopril—coronary artery disease	1.35e-05	0.000139	CcSEcCtD
Boceprevir—Dizziness—Ramipril—coronary artery disease	1.34e-05	0.000138	CcSEcCtD
Boceprevir—Asthenia—Lisinopril—coronary artery disease	1.32e-05	0.000135	CcSEcCtD
Boceprevir—Dizziness—Timolol—coronary artery disease	1.31e-05	0.000135	CcSEcCtD
Boceprevir—Pruritus—Lisinopril—coronary artery disease	1.3e-05	0.000134	CcSEcCtD
Boceprevir—Vomiting—Ramipril—coronary artery disease	1.29e-05	0.000132	CcSEcCtD
Boceprevir—Rash—Ramipril—coronary artery disease	1.28e-05	0.000131	CcSEcCtD
Boceprevir—Dermatitis—Ramipril—coronary artery disease	1.28e-05	0.000131	CcSEcCtD
Boceprevir—Headache—Ramipril—coronary artery disease	1.27e-05	0.00013	CcSEcCtD
Boceprevir—Vomiting—Timolol—coronary artery disease	1.26e-05	0.000129	CcSEcCtD
Boceprevir—Diarrhoea—Lisinopril—coronary artery disease	1.26e-05	0.000129	CcSEcCtD
Boceprevir—Rash—Timolol—coronary artery disease	1.25e-05	0.000128	CcSEcCtD
Boceprevir—Dermatitis—Timolol—coronary artery disease	1.25e-05	0.000128	CcSEcCtD
Boceprevir—Headache—Timolol—coronary artery disease	1.24e-05	0.000127	CcSEcCtD
Boceprevir—Dizziness—Lisinopril—coronary artery disease	1.22e-05	0.000125	CcSEcCtD
Boceprevir—Nausea—Ramipril—coronary artery disease	1.2e-05	0.000124	CcSEcCtD
Boceprevir—Nausea—Timolol—coronary artery disease	1.18e-05	0.000121	CcSEcCtD
Boceprevir—Vomiting—Lisinopril—coronary artery disease	1.17e-05	0.00012	CcSEcCtD
Boceprevir—Rash—Lisinopril—coronary artery disease	1.16e-05	0.000119	CcSEcCtD
Boceprevir—Dermatitis—Lisinopril—coronary artery disease	1.16e-05	0.000119	CcSEcCtD
Boceprevir—Headache—Lisinopril—coronary artery disease	1.15e-05	0.000118	CcSEcCtD
Boceprevir—Nausea—Lisinopril—coronary artery disease	1.09e-05	0.000112	CcSEcCtD
Boceprevir—CYP3A5—Metabolism—SULT1A1—coronary artery disease	2.46e-06	3.26e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—HK1—coronary artery disease	2.46e-06	3.26e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ABCG5—coronary artery disease	2.46e-06	3.26e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GPX4—coronary artery disease	2.46e-06	3.26e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MAPK1—coronary artery disease	2.45e-06	3.25e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CKM—coronary artery disease	2.43e-06	3.23e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—UQCRFS1—coronary artery disease	2.43e-06	3.23e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PPAP2B—coronary artery disease	2.43e-06	3.23e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—HADHA—coronary artery disease	2.43e-06	3.22e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—coronary artery disease	2.43e-06	3.22e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PIK3CA—coronary artery disease	2.41e-06	3.2e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTA1—coronary artery disease	2.4e-06	3.19e-05	CbGpPWpGaD
Boceprevir—CTSK—Immune System—AKT1—coronary artery disease	2.39e-06	3.17e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—LPA—coronary artery disease	2.38e-06	3.15e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AKR1B1—coronary artery disease	2.37e-06	3.14e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HK2—coronary artery disease	2.37e-06	3.14e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PLCB3—coronary artery disease	2.3e-06	3.05e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—APOA5—coronary artery disease	2.28e-06	3.02e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLC27A1—coronary artery disease	2.27e-06	3.01e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALDH6A1—coronary artery disease	2.26e-06	3e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PYGM—coronary artery disease	2.26e-06	3e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CKMT2—coronary artery disease	2.26e-06	3e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SULT4A1—coronary artery disease	2.26e-06	3e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PDK4—coronary artery disease	2.26e-06	3e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—POMC—coronary artery disease	2.26e-06	2.99e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—P4HB—coronary artery disease	2.24e-06	2.96e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CPT1B—coronary artery disease	2.23e-06	2.95e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—LCAT—coronary artery disease	2.23e-06	2.95e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—PLG—coronary artery disease	2.2e-06	2.92e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PLA2G1B—coronary artery disease	2.19e-06	2.91e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—APOA4—coronary artery disease	2.18e-06	2.9e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL6—coronary artery disease	2.14e-06	2.83e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PIK3CA—coronary artery disease	2.12e-06	2.82e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—coronary artery disease	2.12e-06	2.81e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PDHA1—coronary artery disease	2.11e-06	2.8e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GCLM—coronary artery disease	2.11e-06	2.8e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—VCAN—coronary artery disease	2.07e-06	2.74e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ALDOA—coronary artery disease	2.05e-06	2.72e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—TXNRD1—coronary artery disease	2.04e-06	2.71e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP11B2—coronary artery disease	2.04e-06	2.71e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—HMOX1—coronary artery disease	2.03e-06	2.69e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PFKM—coronary artery disease	2.02e-06	2.67e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GK—coronary artery disease	2.02e-06	2.67e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GYG1—coronary artery disease	2.02e-06	2.67e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HMGCS2—coronary artery disease	2.02e-06	2.67e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—LDHA—coronary artery disease	2.02e-06	2.67e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GATM—coronary artery disease	2.02e-06	2.67e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLC22A3—coronary artery disease	2.01e-06	2.67e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—DCN—coronary artery disease	1.99e-06	2.64e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ARNTL—coronary artery disease	1.98e-06	2.63e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HADH—coronary artery disease	1.98e-06	2.63e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—AKT1—coronary artery disease	1.97e-06	2.61e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—APOB—coronary artery disease	1.94e-06	2.58e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—coronary artery disease	1.94e-06	2.57e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ALDH2—coronary artery disease	1.94e-06	2.57e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AK1—coronary artery disease	1.92e-06	2.55e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GCH1—coronary artery disease	1.92e-06	2.55e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—coronary artery disease	1.9e-06	2.52e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—LIPC—coronary artery disease	1.89e-06	2.5e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—HBA1—coronary artery disease	1.89e-06	2.5e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP2C19—coronary artery disease	1.89e-06	2.5e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3C2A—coronary artery disease	1.89e-06	2.5e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL6—coronary artery disease	1.88e-06	2.49e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—APOA2—coronary artery disease	1.88e-06	2.49e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PLA2G2A—coronary artery disease	1.88e-06	2.49e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GPX2—coronary artery disease	1.88e-06	2.49e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—APOC3—coronary artery disease	1.88e-06	2.49e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—LDLR—coronary artery disease	1.87e-06	2.47e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HK1—coronary artery disease	1.86e-06	2.46e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GPX4—coronary artery disease	1.86e-06	2.46e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SULT1A1—coronary artery disease	1.86e-06	2.46e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ABCG5—coronary artery disease	1.86e-06	2.46e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PPAT—coronary artery disease	1.84e-06	2.45e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—UGCG—coronary artery disease	1.84e-06	2.45e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PLCD1—coronary artery disease	1.84e-06	2.45e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—MDH2—coronary artery disease	1.84e-06	2.45e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SLC9A1—coronary artery disease	1.84e-06	2.44e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTT1—coronary artery disease	1.84e-06	2.44e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HADHA—coronary artery disease	1.84e-06	2.43e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GCLC—coronary artery disease	1.82e-06	2.42e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CETP—coronary artery disease	1.82e-06	2.42e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTA1—coronary artery disease	1.81e-06	2.41e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—coronary artery disease	1.81e-06	2.4e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SDC1—coronary artery disease	1.8e-06	2.39e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—LPA—coronary artery disease	1.79e-06	2.38e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PGM1—coronary artery disease	1.78e-06	2.35e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PLCB3—coronary artery disease	1.74e-06	2.3e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—AKT1—coronary artery disease	1.74e-06	2.3e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—APOA5—coronary artery disease	1.72e-06	2.28e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PYGB—coronary artery disease	1.72e-06	2.27e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CKB—coronary artery disease	1.72e-06	2.27e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PSMA6—coronary artery disease	1.7e-06	2.26e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PSMB5—coronary artery disease	1.7e-06	2.26e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—P4HB—coronary artery disease	1.69e-06	2.24e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CTGF—coronary artery disease	1.66e-06	2.2e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PLA2G1B—coronary artery disease	1.66e-06	2.19e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—coronary artery disease	1.65e-06	2.19e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—HMGCR—coronary artery disease	1.65e-06	2.18e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GOT2—coronary artery disease	1.65e-06	2.18e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—DLAT—coronary artery disease	1.61e-06	2.14e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTM2—coronary artery disease	1.61e-06	2.14e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—COX5B—coronary artery disease	1.61e-06	2.14e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PLIN1—coronary artery disease	1.61e-06	2.14e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PFKFB3—coronary artery disease	1.61e-06	2.14e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—VCAN—coronary artery disease	1.56e-06	2.07e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALDOA—coronary artery disease	1.55e-06	2.05e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—APOA1—coronary artery disease	1.54e-06	2.04e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SULT1E1—coronary artery disease	1.53e-06	2.03e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PLCB1—coronary artery disease	1.52e-06	2.01e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—DCN—coronary artery disease	1.5e-06	1.99e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ABCA1—coronary artery disease	1.47e-06	1.95e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALDH2—coronary artery disease	1.46e-06	1.94e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HK2—coronary artery disease	1.46e-06	1.93e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AKR1B1—coronary artery disease	1.46e-06	1.93e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—LIPC—coronary artery disease	1.43e-06	1.89e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HBA1—coronary artery disease	1.43e-06	1.89e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3C2A—coronary artery disease	1.43e-06	1.89e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP2C19—coronary artery disease	1.43e-06	1.89e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GOT1—coronary artery disease	1.42e-06	1.89e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GGT1—coronary artery disease	1.42e-06	1.89e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—APOC3—coronary artery disease	1.42e-06	1.88e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—LDLR—coronary artery disease	1.41e-06	1.87e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC27A1—coronary artery disease	1.4e-06	1.85e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLC9A1—coronary artery disease	1.39e-06	1.84e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTT1—coronary artery disease	1.39e-06	1.84e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GCLC—coronary artery disease	1.37e-06	1.82e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CETP—coronary artery disease	1.37e-06	1.82e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—LCAT—coronary artery disease	1.37e-06	1.82e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CPT1B—coronary artery disease	1.37e-06	1.82e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SDC1—coronary artery disease	1.36e-06	1.8e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	1.35e-06	1.79e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—APOA4—coronary artery disease	1.35e-06	1.78e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PDHA1—coronary artery disease	1.3e-06	1.72e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GCLM—coronary artery disease	1.3e-06	1.72e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PSMB5—coronary artery disease	1.28e-06	1.7e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PSMA6—coronary artery disease	1.28e-06	1.7e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTP1—coronary artery disease	1.28e-06	1.69e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PPARGC1A—coronary artery disease	1.27e-06	1.68e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—HMOX1—coronary artery disease	1.26e-06	1.67e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—TXNRD1—coronary artery disease	1.26e-06	1.67e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP11B2—coronary artery disease	1.26e-06	1.67e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CTGF—coronary artery disease	1.25e-06	1.66e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HMGCR—coronary artery disease	1.24e-06	1.65e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GOT2—coronary artery disease	1.24e-06	1.65e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CAT—coronary artery disease	1.24e-06	1.65e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC22A3—coronary artery disease	1.24e-06	1.64e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ARNTL—coronary artery disease	1.22e-06	1.62e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HADH—coronary artery disease	1.22e-06	1.62e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	1.22e-06	1.62e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—APOB—coronary artery disease	1.21e-06	1.6e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTM1—coronary artery disease	1.17e-06	1.56e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GPX2—coronary artery disease	1.16e-06	1.54e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—APOA2—coronary artery disease	1.16e-06	1.54e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	1.16e-06	1.54e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—LPL—coronary artery disease	1.15e-06	1.53e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ABCG5—coronary artery disease	1.14e-06	1.52e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GPX4—coronary artery disease	1.14e-06	1.52e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HK1—coronary artery disease	1.14e-06	1.52e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SULT1A1—coronary artery disease	1.14e-06	1.52e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PLCB1—coronary artery disease	1.14e-06	1.52e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HADHA—coronary artery disease	1.13e-06	1.5e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GPX1—coronary artery disease	1.12e-06	1.49e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTA1—coronary artery disease	1.12e-06	1.48e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ABCA1—coronary artery disease	1.11e-06	1.47e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—LPA—coronary artery disease	1.11e-06	1.47e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CD36—coronary artery disease	1.09e-06	1.45e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PPP2CA—coronary artery disease	1.08e-06	1.43e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GGT1—coronary artery disease	1.07e-06	1.42e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GOT1—coronary artery disease	1.07e-06	1.42e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PLCB3—coronary artery disease	1.07e-06	1.42e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—APOA5—coronary artery disease	1.06e-06	1.4e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—P4HB—coronary artery disease	1.04e-06	1.38e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—MTHFR—coronary artery disease	1.04e-06	1.38e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	1.02e-06	1.35e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AGT—coronary artery disease	9.86e-07	1.31e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—APOE—coronary artery disease	9.66e-07	1.28e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTP1—coronary artery disease	9.64e-07	1.28e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—VCAN—coronary artery disease	9.61e-07	1.27e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PPARGC1A—coronary artery disease	9.55e-07	1.27e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—APOA1—coronary artery disease	9.55e-07	1.27e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALDOA—coronary artery disease	9.54e-07	1.26e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HMOX1—coronary artery disease	9.51e-07	1.26e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CAT—coronary artery disease	9.38e-07	1.24e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—DCN—coronary artery disease	9.26e-07	1.23e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—APOB—coronary artery disease	9.11e-07	1.21e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALDH2—coronary artery disease	9.01e-07	1.19e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTM1—coronary artery disease	8.86e-07	1.17e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—LIPC—coronary artery disease	8.78e-07	1.16e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HBA1—coronary artery disease	8.78e-07	1.16e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP2C19—coronary artery disease	8.78e-07	1.16e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	8.78e-07	1.16e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—APOC3—coronary artery disease	8.73e-07	1.16e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—LPL—coronary artery disease	8.7e-07	1.15e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—LDLR—coronary artery disease	8.67e-07	1.15e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC9A1—coronary artery disease	8.57e-07	1.14e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTT1—coronary artery disease	8.57e-07	1.14e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GPX1—coronary artery disease	8.48e-07	1.12e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GCLC—coronary artery disease	8.47e-07	1.12e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CETP—coronary artery disease	8.47e-07	1.12e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PPARG—coronary artery disease	8.41e-07	1.12e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SDC1—coronary artery disease	8.38e-07	1.11e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—POMC—coronary artery disease	8.3e-07	1.1e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CD36—coronary artery disease	8.26e-07	1.1e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PPP2CA—coronary artery disease	8.16e-07	1.08e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PSMA6—coronary artery disease	7.91e-07	1.05e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PSMB5—coronary artery disease	7.91e-07	1.05e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—MTHFR—coronary artery disease	7.83e-07	1.04e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CTGF—coronary artery disease	7.73e-07	1.02e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HMGCR—coronary artery disease	7.66e-07	1.02e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GOT2—coronary artery disease	7.66e-07	1.02e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ALB—coronary artery disease	7.57e-07	1e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AGT—coronary artery disease	7.44e-07	9.86e-06	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—APOE—coronary artery disease	7.29e-07	9.66e-06	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NOS3—coronary artery disease	7.24e-07	9.6e-06	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—APOA1—coronary artery disease	7.21e-07	9.55e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PLCB1—coronary artery disease	7.04e-07	9.34e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ABCA1—coronary artery disease	6.83e-07	9.05e-06	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTGS2—coronary artery disease	6.62e-07	8.78e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GOT1—coronary artery disease	6.61e-07	8.77e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GGT1—coronary artery disease	6.61e-07	8.77e-06	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PPARG—coronary artery disease	6.35e-07	8.42e-06	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—POMC—coronary artery disease	6.26e-07	8.3e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTP1—coronary artery disease	5.94e-07	7.88e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	5.88e-07	7.8e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HMOX1—coronary artery disease	5.86e-07	7.77e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CAT—coronary artery disease	5.78e-07	7.66e-06	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALB—coronary artery disease	5.71e-07	7.57e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—APOB—coronary artery disease	5.61e-07	7.44e-06	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NOS3—coronary artery disease	5.46e-07	7.24e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTM1—coronary artery disease	5.46e-07	7.24e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—LPL—coronary artery disease	5.36e-07	7.1e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GPX1—coronary artery disease	5.23e-07	6.93e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CD36—coronary artery disease	5.09e-07	6.75e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PPP2CA—coronary artery disease	5.03e-07	6.67e-06	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTGS2—coronary artery disease	4.99e-07	6.62e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—MTHFR—coronary artery disease	4.82e-07	6.4e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AGT—coronary artery disease	4.58e-07	6.08e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—APOE—coronary artery disease	4.49e-07	5.95e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—APOA1—coronary artery disease	4.44e-07	5.89e-06	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CA—coronary artery disease	4.07e-07	5.4e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PPARG—coronary artery disease	3.91e-07	5.19e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—POMC—coronary artery disease	3.86e-07	5.12e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALB—coronary artery disease	3.52e-07	4.66e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NOS3—coronary artery disease	3.36e-07	4.46e-06	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AKT1—coronary artery disease	3.33e-07	4.41e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTGS2—coronary artery disease	3.08e-07	4.08e-06	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CA—coronary artery disease	3.07e-07	4.07e-06	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AKT1—coronary artery disease	2.51e-07	3.33e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CA—coronary artery disease	1.89e-07	2.51e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AKT1—coronary artery disease	1.55e-07	2.05e-06	CbGpPWpGaD
